Undersea Hyperbar M
The most recent articles from:
November 2017
-
Undersea Hyperbar M · Nov 2017
Observational StudyHyperbaric oxygen therapy as an adjuvant to source control in necrotizing soft tissue infections.
Necrotizing soft tissue infections (NSTI) are rare but potentially lethal disorders, and adequate management is time- and resource-demanding. This study aims to assess whether variations in the treatment modalities - surgery, hyperbaric oxygen (HBO₂) therapy and negative pressure wound therapy - had an impact on the length to definitive source control in NSTI patients who underwent HBO₂. ⋯ More intensive HBO₂ protocols with earlier and more frequent sessions shorten the time until definitive source control in necrotizing soft tissue infections, potentially lowering the impact of systemic effects of infection and complications associated with organ dysfunction.